UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | R | S | T | V | W | Z
Number of items: 92.


Adams, VC; Hunt, JRF; Martinelli, R; Palmer, R; Rook, GAW; Rosa Brunet, L; (2003) Mycobacterium vaccae induces a CD11c+ population that produces regulatory cytokines in the lungs of allergic mice. Presented at: UNSPECIFIED.

Agalou, S; Ahmed, N; Dawnay, A; Thornalley, PJ; (2003) Removal of advanced glycation endproducts in clinical renal failure by peritoneal dialysis and haemodialysis. Biochemical Society Transactions , 31 pp. 1394-1396.

Anand, A.; (2003) Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systematic lupus erythematosus (SLE). Doctoral thesis, University of London. Green open access

Aspinall, R; Henson, SM; Pido-Lopez, J; (2003) My T's gone cold, I'm wondering why. Nat Immunol , 4 (3) pp. 203-205.


Balogun, MA; Laurichesse, H; Ramsay, ME; Sellwood, J; Westmoreland, D; Paver, WK; Pugh, SF; (2003) Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Communicable Disease and Public Health , 6 (1) pp. 34-39.


Cathcart, S; Boyle, J; Sabin, CA; Johnson, MA; Zuckerman, JN; (2003) Pre-travel preparation and outcome of HIV-infected travellers from a UK clinic. Travel Medicine and Infectious Disease , 1 (2) pp. 114-118. 10.1016/S1477-8939(03)00024-3.

Cepeda, J; Hayman, S; Whitehouse, T; Kibbler, CC; Livermore, D; Singer, M; Wilson, APR; (2003) Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit. J ANTIMICROB CHEMOTH , 52 (3) 533 - 534. 10.1093/jac/dkg369.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Jones, K; Kwaku, F; Taylor, L; (2003) Source isolation in intensive care units does not reduce spread of MRSA beyond that achieved by universal precautions: a prospective two-centre study. Presented at: 13th European Congress of Clinical Microbiology and Infectious Diseases.


Davies, AK; Woo, P; (2003) Cells cytokines and other mediators. In: Maddison, PJ and Isenberg, DA and Woo, P and Glass, DN, (eds.) Oxford Textbook of Rheumatology. (pp. 399-401). Oxford University Press: Oxford.

Davies, K; Woo, P; (2003) Non-rheumatic causes of musculoskeletal symptoms in childhood (I). Acta Pediatr Esp. , 61 (9) pp. 445-458.

Dawnay, A; (2003) Renal clearance of glycation adducts; anti-glycation defence in uraemia and dialysis. Biochemical Society Transactions , 31 pp. 1386-1389.

Deborde, S; Schofield, JN; Rademacher, TW; (2003) Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. Journal of Reproductive Immunology , 59 pp. 277-294.

Denning, DW; Kibbler, CC; Barnes, RA; (2003) Standards of care for invasive fungal infections. The Lancet Infectious Diseases , 3 (4) pp. 230-240. 10.1016/S1473-3099(03)00580-2.

Dervisevic, S; PILLAY, D; (2003) Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. Journal of HIV Therapy , 8 (4) pp. 89-95.


Elst, E; van Royen, A; van der Net, J; Kuis, W; Pilkington, C; Woo, P; (2003) Case Discussion-Juvenile Dermatomyositis. Pediatric Rheumatology Online Journal , 1 (2) pp. 77-83.


Fife, MS; Jeffery, R; Ogilvie, EM; Woo, P; (2003) Increased Affinity Of A Transcription Factor Complex For The -174G Allele Of The IL-6 Gene Augments Its Transcriptional Activity: Rationale For Susceptibility To Systemic JIA. Presented at: UNSPECIFIED.


Gao, L; Xue, S; Hasserijan, R; Cotter, F; Kaeda, J; Goldman, JM; Dazzi, F; (2003) Human cytotoxic T-lymphocytes specific for Wilms tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in NOD/SCID recipients. Transplantation , 75 pp. 1429-1436.

Garson, JA; (2003) Endogenous retrovirusesin MS. International MS Journal , 10 (1) pp. 20-21. Green open access

Gathercole, L; Ogilvie, EM; Fisher, SA; Donn, R; Thomson, W; BPRG Study Group, ; Fife, MS; (2003) Cytokine Interaction In Disease. Presented at: UNSPECIFIED.

Gathercole, L; Ogilvie, EM; Fisher, SA; Donn, R; Thomson, W; BPRG Study Group, ; Fife, MS; (2003) Epistatic Interactions In Systemic JIA. Clin.Exp.Rheumatol. , 21 (4) 545-.

Gent, AM; Zuckerman, JN; (2003) A review of the Infection Control Policies for Blood Borne Viruses as applied to Non Governmental Organisations (NGOs). Journal of Travel Medicine & Infectious Disease , 1 pp. 29-33.

Gilleece, Y; Torti, C; Mandalia, S; Gazzard, BG; PILLAY, D; Pozniak, AL; (2003) The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients. HIV Medicine , 4 (4) pp. 305-310.

Gregorio, GV; Choudhuri, K; Ma, Y; Pensati, P; Iorio, R; Grant, P; Garson, J; (2003) Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clinical and Experimental Immunology , 133 (3) pp. 404-413. 10.1046/j.1365-2249.2003.02229.x.


Hajioff, D; Enever, Y; Quiney, R; Zuckerman, JN; MacDermot, K; Mehta, A; (2003) Hearing loss in Fabry Disease: the effect of agalsidase alfa replacement therapy. Journal of Inherited Metabolic Disease , 26 (8) pp. 787-794.

Hajioff, D; Goodwin, S; Quiney, R; Zuckerman, JN; MacDermot, KD; Mehta, A; (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatrica , 92 (443) pp. 28-30.

Hall, C; Woo, P; (2003) Disease of bone and cartilage in children. In: Isenberg, D and Maddison, PJ and Woo, P and Glass, D and Breedveld, FC, (eds.) Oxford Textbook of Rheumatology. (pp. 1164-1173). Oxford University Press: Oxford,UK.

Henson, SM; Aspinall, R; (2003) Aging and the Immune System. In: Aspinall, R, (ed.) Aging of organs and systems. Springer Netherlands

Hu, JC; Coffin, RS; (2003) Oncolytic herpes simplex virus for tumour therapy. International Review of Neurobiology , 55 pp. 165-184.


Isaac, A; PILLAY, D; (2003) New drugs for treating drug resistant HIV-1. Sexually Transmitted Diseases , 79 (3) pp. 176-178.


Johnson, VA; Brun-Vezinet, F; Clotet, B; Conway, B; D'Aquila, RT; Demeter, LM; Kuritzkes, DR; (2003) Drug resistance mutations in HIV-1. Topics in HIV Medicine , 11 (6) pp. 215-221.

Jong, EJ; Zuckerman, J; (2003) Travellers Vaccines. [Book]. (1st ed.). BC Decker


Kellam, P; Liu, X; (2003) Experimental use of DNA arrays. In: Orengo, CA and Jones, DT and Thornton, JM, (eds.) Bioinformatics: gene proteins and computers. BIOS Scientific Publishers Limited

Kibbler, CC; (2003) Infections Associated with Neutropenia. In: Finch, RG and Greenwood, D and Norrby, SR and Whitley, RJ, (eds.) Antibiotic and Chemotherapy. Churchill Livingstone: Edinburgh.

Kibbler, CC; Mele, A; Paterson, PJ; Prentice, HG; (2003) Response to Martino and Cordonnier. Bone Marrow Transplantation , 31 (7) p. 619.

Kibbler, CC; Ruddy, M; (2003) Endoscopic decontamination: an audit and practical review. A reply. Journal of Hospital Infection , 54 (1) p. 84.

Kinloch, S; (2003) The QUEST Trial. Immune reconstitution & control of HIV. Presented at: RIGHT, Stresa, Italy.

Kinloch, S; (2003) The role of early treatment for HIV. Presented at: Federation of Infection Societies, Cardiff, UK.

Kotter, I; Treusch, M; Vonthein, R; Zierhut, M; Eckstein, A; Ness, T; Gunaydin, I; (2003) Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behcet's disease and influence on cells of the immune system: results of an open four center trial. In: ARTHRITIS RESEARCH & THERAPY. (pp. S2 - S3). BIOMED CENTRAL LTD


Liu, BL; Robinson, M; Han, ZQ; Branston, RH; English, C; Reay, P; McGrath, Y; (2003) ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Therapy , 10 (4) pp. 292-303. 10.1038/sj.gt.3301885.

Liu, X; Kellam, P; (2003) Mining gene expression data. In: Orengo, C and Jones, T, (eds.) Bioinformatics: genes proteins and computers. BIOS Scientific Publishers Limited

Livermore, P; Wilkinson, NMR; Wythe, H; Woo, P; (2003) Is there a role for a paediatric rheumatology clinical research nurse? Presented at: UNSPECIFIED.

Lydyard, PM; Whelan, A; Fanger, MW; (2003) Instant Notes in Immunology. [Book]. Instant Notes. (2nd ed.). Bios, Taylor Francis: Oxford.


Marchant, A; Appay, V; van der Sande, M; Dulphy, N; Liesnard, C; Kidd, M; Kaye, S; (2003) Mature CD8+ T lymphocyte response to viral infection during fetal life. Journal of Clinical Investigation , 111 (11) pp. 1747-1755. 10.1172/JCI200317470.

Martinelli, R; Hunt, JRF; Rook, GAW; Rosa Brunet, L; (2003) Effects of Mycobacterium vaccae on peritoneal exudate cells of napve mice. Presented at: UNSPECIFIED.

Morris, EC; Harrison, G; Bailey, CC; Hann, IM; Gibson, BE; Richards, S; Webb, DK; (2003) Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia. British Journal of Haematology , 120 pp. 787-789.

Morris, EC; Rebello, P; Thomson, KJ; Peggs, KS; Kyriacou, C; Goldstone, AH; Mackinnon, S; (2003) Pharmacokinetics of alemtuzumab (CAMPATH-1H) used for in vivo and in vitro T-cell depletion in allogeneic transplants: relevance for early adoptive immunotherapy and infectious complications. BLOOD , 102 pp. 404-406. 10.1182/blood-2002-09-2687.


Nelson, M; Portsmouth, S; Stebbing, J; Atkins, M; Barr, A; Matthews, G; PILLAY, D; (2003) An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals. AIDS , 17 (1) F7-10.

Newton, R; Ziegler, J; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. British Journal of Cancer , 89 (3) pp. 502-504.

Newton, R; Ziegler, J; Bourboulia, D; Casaborne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer , 103 (2) pp. 226-232.

Nothdurft, HD; Dietrich, M; Zuckerman, JNK; J, K; P, S; R, ; (2003) Rapid protection against Hepatitis A and B using an accelerated vaccination schedule; comparison of combined vaccine, Twinrix?, with separate vaccines. BioDrugs , 17 pp. 15-18.


Paine, MA; Rodeck, CH; Williams, PJ; Rademacher, TW; (2003) Possible involvement of inositol phosphoglycan-P in human parturition. Journal of Reproductive Immunology , 59 pp. 267-275.

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Yong, K; Nathwani, A; Heelan, B; (2003) Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated versus those using IgVh unmutated genes. Presented at: UNSPECIFIED.

Porakishvili, N; Slovick, A; Jewell, AP; Youinou, PY; Nathwani, K; Stevenson, F; Clark, EA; (2003) Activation of B-CLL cells by CD180 monoclonal antibodies: responders and non-responders. BLOOD , 102 432a-.


Ramirez, F; Ghani, Y; Stauss, HJ; (2003) Incomplete tolerance to the tumour-associated antigen MDM2. International Immunology , 16 (2) pp. 327-334.

Riley, P; Maillard, S; Woo, P; Pilkington, C; (2003) Cyclophosphamide Use In JDM - Retrospective Casenote Review Of Efficacy And Safety. Arch.Dis.Child , 88 (Suppl.) A37-.

Riley, P; Maillard, S; Woo, P; Pilkington, C; (2003) Cyclophosphamide use in JDM - Retrospective casenote review of efficacy and safety. Pediatric Rheumatology Online Journal , 1 (4) 125-.

Ruperto, N; Ravelli, A; Murray, KJ; Lovell, DJ; Andersson-Gare, B; Feldman, BM; Garay, S; (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) , 42 (12) pp. 1452-1459.


Skoufos, L; Topley, N; Cooker, L; Dawnay, A; Millar, DJ; Holmes, CJ; Faict, D; (2003) The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Kidney International , 88 (su S94-S99.

Stauss, HJ; Bellantuono, I; Hsu, SC; Ramirez, F; (2003) Tumour Immunology. In: Lightstone, E and Friedland, J, (eds.) Infection and Immunity. Martin Dunitz

Steffen, R; Acar, J; Walker, E; Zuckerman, JN; (2003) Cholera: Assessing the risk to travellers and identifying methods of protection. Journal of Travel Medicine & Infectious Disease , 1 pp. 80-88.


Taams, LS; Vukmanovic-Stejic, M; Salmon, M; Akbar, AN; (2003) Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance. Transplant Immunology , 11 pp. 277-285.

Temperton, NJ; Quenelle, DC; Lawson, KM; Zuckerman, J; N, K; E, G; P D, E; (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminium phosphate and CpG oligodeoxynucleotides (ODN). Journal of Medical Virology , 70 (1) pp. 86-90.

Thornalley, PJ; Battah, S; Ahmed, N; Karachalias, N; Agalou, S; Babei-Jadidi, R; Dawnay, A; (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochemical Journal , 375 pp. 581-592.

Twine, N; Kelberman, D; Ogilvie, EM; Woo, P; Fife, M; (2003) Does the polymorphic IL6 AnTn tract modify the effect of the -174 SNP in systemic arthritis? Biosystem Solutions , 7 pp. 8-9.



Van Herck, K; Zuckerman, J; Castelli, F; Van Damme, P; Walker, E; Steffen, R; (2003) Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study. Journal of Travel Medicine , 10 (2) pp. 75-78.

Van Herck, K; Zuckerman, JN; Castelli, F; Van Damme, P; Walker, E; Steffen, R; (2003) Travellers' knowledge, attitudes and practices on prevention of infectious diseases - results from a pilot study. Journal of Travel Medicine , 10 pp. 75-78.


Wedderburn, LR; Patel, A; Varsani, H; Pharoah, D; Tatham, R; Woo, P; (2003) Immunoregulation in juvenile idiopathic arthritis. Presented at: UNSPECIFIED.

Weiss, RA; (2003) Cross-species infections. Current Topics in Microbiology and Immunology , 278 pp. 48-71.

Weiss, RA; (2003) HIV and AIDS in relation to other pandemics. EMBO Reports , 4 S10-S14.

Weiss, RA; (2003) Human receptors for retroviruses. In: Sugumura, K and Uchiyama, T and Matsuoka, M and Kannagi, M, (eds.) Gann Monograph on Cancer Research No 50: Two decades of adult T-cell leukaemia and HTLV-1 research. Japan Scientific Societies Press

Wilkinson, NMR; Bladen, M; Khair, K; Leisner, R; Woo, P; (2003) Rehabilitative physiotherapy and intra-articular steroids in the management of haemophilic arthropathy. Pediatric Rheumatology Online Journal , 1 (5) 196-.

Wilkinson, NMR; Livermore, P; Woo, P; (2003) Severe autoimmune disease in siblings of a somalian family and response to treatment with Infliximab. Pediatric Rheumatology Online Journal , 1 (5) 161-.

Wilkinson, NMR; Livermore, PA; Wythe, H; Woo, P; (2003) Phase II safety study of an anti-interleukin-6 receptor antibody in systemic juvenile idiopathic arthritis. Presented at: UNSPECIFIED.

Wilson, APR; (2003) Antibacterial prophylaxis in surgery. 1- Gastrointestinal and biliary surgery. Drug and Therapeutics Bulletin , 41 (11) pp. 83-86.

Wilson, APR; (2003) Infections in Obstetrics. In: Williams, JD and Taylor, EW, (eds.) Infection in Surgical Practice. (pp. 271-280). Arnold: London.

Wilson, P; Andrews, JA; Charlesworth, R; Walesby, R; Singer, M; Farrell, DJ; Robbins, M; (2003) Linezolid resistance in clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy , 51 (1) pp. 186-188.

Woo, P; (2003) Recent advances in the management of juvenile idiopathic arthritis. Current Paediatrics , 13 (5) pp. 335-340. 10.1016/S0957-5839(03)00075-7.

Woo, P; (2003) Biological Therapies for Juvenile Arthritis. In: Smolen, J and Lipsky, P, (eds.) Targeted Therapies In Rheumatology. (pp. 515-524). Martin Dunitz: London.

Woo, P; (2003) Targeted therapies in human and experimental rheumatic diseases: Juvenile arthtitis. In: Smolen, J and Lipsky, P, (eds.) Targeted Therapies In Rheumatology. (pp. 515-524). Martin Dunitz: London.


Ziegler, J; Newton, R; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) Risk factors for Kaposi's sarcoma: A case-control study of HIV- seronegative people in Uganda. International Journal of Cancer , 103 (2) pp. 233-240.

Zuckerman, J; West, D; Kassianos, G; (2003) "Dukoral": Cholera. [Book]. CSF Medical Communications

Zuckerman, JN; (2003) 1. Vaccination priorities in travel. In: The Art of Travel Medicine. 2003; 17:1 6. BioDrugs , 17 pp. 1-6.

Zuckerman, JN; (2003) 1Avian influenza outbreak. Journal of Travel Medicine & Infectious Disease , 1 pp. 199-200.

Zuckerman, JN; (2003) Introduction to the journal of travel medicine & infectious disease. Journal of Travel Medicine & Infectious Disease , 1 pp. 1-2.

Zuckerman, JN; (2003) Review and Recommendations to Seafarers on Immunisations and Prevention of Malaria including the use of Prophylaxis. Maritime & Coastguard Agency of the Department of Transport, United Kingdom.

Zuckerman, JN; Nothdurft, HD; Dietrich, M; Knobloch, J; Kern, P; Sanger, R; (2003) Rapid protection against hepatitis A and B following an accelerated schedule of a combined hepatitis A/B vaccine. Presented at: Viral Hepatitis and Liver Disease; Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease 2000.

Zuckerman, JN; Van Damme, P; Van Herck, K; Lscher, T; (2003) Vaccination options for last-minute travellers in need of travel-related prophylaxis against hepatitis A & B and typhoid fever: a practical guide. Journal of Travel Medicine & Infectious Disease , 1 pp. 219-226.

Zuckerman, JN; Zuckerman, AJ; (2003) Hepatitis Viruses. In: Cohen, J and Powderly, WG, (eds.) Infectious Diseases. (pp. 2007-2021). Elsevier Science

Zuckerman, JN; Zuckerman, AJ; (2003) Viral Hepatitis. In: Cook, GC, (ed.) Manson's Tropical Diseases. (pp. 707-723). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Zuckerman, JN; Zuckerman, AJ; (2003) Prevention & treatment of viral hepatitis. In: Trafton, J and Gordon, W, (eds.) Best Practices in the Behavioural Management of Chronic Disease. Institute for Brain Potential

Zulian, F; De Oliveira, SKF; Lehman, TH; Punaro, L; Higgins, G; Harper, J; Woo, P; (2003) Juvenile Localized Scleroderma: Clinical Epidemiological Features of 688 Patients. Presented at: UNSPECIFIED.

This list was generated on Sun Nov 27 06:13:48 2016 GMT.